They either send signals to your adipose tissues to release stored fat to provide energy or release growth hormones, which boost fat metabolism
GH can affect glucose FDA Status AOD-9604 Not approved (GRAS for the oral form) Tesamorelin FDA-approved (Egrifta, 2010) Human Evidence AOD-9604 Modest weight-loss results in trials Tesamorelin 2 Phase 3 RCTs, 816 patients Fat Targeted AOD-9604 General adipose, including abdominal Tesamorelin Visceral (deep belly) fat specifically Best-For AOD-9604 Fat support without shifting hormones Tesamorelin Deep visceral fat
and is not approved for human therapeutic use
Some people need a quick energy boost every week or two, while others do best with monthly maintenance
This is not unheard of, as drugs like pioglitazone and acipimox both reduce metabolic complications without treating obesity at all
It helps restore gut integrity, making it a powerful tool for individuals dealing with leaky gut syndrome, IBS, Crohns disease, and gastritis